BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, October 1, 2023
Home » Keywords » Zika virus

Items Tagged with 'Zika virus'

ARTICLES

Infection

Beijing Entaiwei Medicine Science Technology discovers new prodrugs of β-D-N4-hydroxycytidine for viral infections

Aug. 23, 2023
No Comments
Beijing Entaiwei Medicine Science Technology Co. Ltd. has described prodrugs of β-D-N4-hydroxycytidine reported to be useful for the treatment of viral infections.
Read More
Infection

Gilead Sciences discloses new compounds for Zika virus infection

Dec. 15, 2022
No Comments
Gilead Sciences Inc. has presented tetracyclic compounds reported to be useful for the treatment of Zika virus infection.
Read More
Infection

Gilead Sciences identifies new compounds for Zika virus infection

Dec. 13, 2022
No Comments
Gilead Sciences Inc. has presented pentacyclic derivative compounds reported to be useful for the treatment of Zika virus infection.
Read More
Pharmaceutical manufacturing

Moderna invests in UK manufacturing and research, answering call to prep for fast response to future ‘Disease X’

June 22, 2022
By Richard Staines
No Comments
While the biopharma industry was widely praised for its fast response to the COVID-19 pandemic, moves are afoot to ensure that the world is better prepared in case another pandemic hits. Moderna Inc. was one of the companies that blazed a trail in the early stages of the pandemic with its revolutionary mRNA vaccine. Now the firm is investing in manufacturing and R&D in the U.K. to make good on a pledge to respond to the next global disease threat within 100 days of its detection.
Read More
Gloved hand holding petri dish in lab

Zika-specific therapy found to protect fetal mouse brains

Nov. 11, 2021
By John Fox
No Comments
A Chinese study led by scientists at Nanjing University is the first to show that modified small extracellular vesicles can cross the placenta and blood-brain barrier to target drug delivery in mice infected with the Zika virus, in which they were shown to significantly reduce fetal neurological damage, including microcephaly.
Read More
Tiger mosquito

Aberrant NAD+ metabolism underlies Zika microcephaly

Aug. 17, 2021
By John Fox
No Comments
A multi-omics analysis led by Chinese scientists at Tsinghua University in Beijing has demonstrated that aberrant metabolism of the co-enzyme nicotinamide adenine dinucleotide (NAD+) was responsible for microcephaly induced by Zika virus infection during pregnancy.
Read More
Hands holding petri dish

Antibody protects broadly against flaviviruses, without ADE

Jan. 12, 2021
By John Fox
No Comments
A study led by Australian researchers at the University of Queensland has shown that a newly developed antibody targets the flavivirus nonstructural protein 1 and was shown to reduce viremia and improve survival in mouse models of dengue, Zika and West Nile infections.
Read More
Coronavirus viral membrane

Mexican university basing COVID-19 vaccine on Zika, dengue

May 13, 2020
By Sergio Held
No Comments
CAJICA, Colombia – Previous research to develop vaccines for dengue and Zika virus could become the cornerstone for a vaccine against COVID-19, which the Autonomous University of Mexico (UNAM) is working on.
Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Sept. 29, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for September 29, 2023.
  • Illustration of Alzheimer’s in the brain.

    Study identifies cause of death for Alzheimer’s neurons

    BioWorld
    By creating a new mouse model of Alzheimer’s disease that better recapitulated how the disease plays out in humans, investigators at KU Leuven have gained new...
  • 3D illustration of cancer in crosshairs

    Dato data lack means upside for Gilead; Padcev 'must-win' does win

    BioWorld
    Upbeat phase III findings outweighed less encouraging late-stage trial news, as big pharma provided a mixed bag of cancer findings – with one data batch to form...
  • Apple Computer Inc. logo

    Apple scores win over Masimo for patents for physiological detectors, but ITC decision awaits

    BioWorld MedTech
    Apple Inc., of Cupertino, Calif., has prevailed over Masimo Corp., in a ruling at the U.S. Court of Appeals for the Federal Circuit, an outcome that invalidated...
BioFuture ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing